ALLO-501A
Phase 2- Indications
- Large B-cell lymphoma
Company intelligence / Profile preview
Allogene Overland Biopharm
Shanghai, Shanghai Shi, Chinair.allogene.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Allogene Overland is a joint venture focused on developing, manufacturing, and commercializing allogeneic CAR T cell therapies for cancer patients across Greater China, Taiwan, South Korea, and Singapore. The company holds exclusive rights to develop four key allogenic CAR-T candidates targeting BCMA, CD70, FLT3, and DLL3. Several programs are in preclinical or early clinical phases as of 2025. The parent companies have demonstrated promising results with these modalities globally but local pivotal data is pending.
- Therapeutic areas
- Oncology
- Modalities
- Allogeneic CAR T cell therapies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Joint venture between two major biotechs—Allogene Therapeutics Inc. and Overland PharmaceuticalsBacked by Hillhouse Capital via the involvement of Overland Pharmaceuticals
Beyond the preview
Go deeper on Allogene Overland Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allogene Overland Biopharm.